Sunday, July 13, 2008

[StemCells] Stem Cell Tourism

Stem-Cell Tourism Troubles Experts
Posted on: Sunday, 13 July 2008, 06:00 CDT
By Marie McCullough, The Philadelphia Inquirer

Jul. 13--In February, Marcela DeVivo took her baby son to the
Dominican Republic and paid $30,000 to have him injected with blood
stem cells from aborted fetuses.

Nathan, who turns 2 next month, was born with the hemispheres of his
brain fused. He is physically and mentally handicapped.

DeVivo is among a growing number of Americans spending up to $75,000
in the hope that clinics in developing countries have realized the
dream of regenerative medicine: using stem cells to fix the so-far
unfixable.

From Guatemala to Ukraine, dozens of stem-cell purveyors are selling
that dream over the Internet. They say they are helping patients whom
mainstream medicine cannot. And they purport to treat a stunning list
of illnesses, especially incurable conditions such as Parkinson's,
cerebral palsy and paralysis.

Their Web sites, many loaded with patient testimonials, offer little
or no scientific evidence to support their claims.

While no one knows exactly how big this new form of "medical tourism"
has grown, it is booming. One of the biggest stem-cell firms, Beike
Biotech -- whose slogan promises "tomorrow's treatments today" --
says it has treated 3,000 Chinese and foreign patients at its 24
hospital clinics in China.

Mainstream researchers condemn stem-cell tourism as unethical and
dangerous, if not fraudulent. They urge patients to wait for rigorous
studies.

Wise Young, an internationally known spinal-cord-injury researcher at
Rutgers University, declared: "Let's say these guys are making
$20,000 per patient. They're making hundreds of millions of dollars.
They can't take time to document it and publish it? This is the wrong
way to do it."

For many patients, the proper way -- years of animal studies followed
by arduous human testing -- is too slow. They hope the experimental
cells hit the right targets, like magic bullets, even if humans are
shooting in the dark.

"I went to the Dominican Republic expecting a miracle," DeVivo, of
Valencia, Calif., wrote on her blog, prayfornathan.org. "Will he walk
out of the clinic? Maybe he will say his first full, clear word. What
will it be?"

Reprogramming cells A decade ago, when embryonic stem cells were
first isolated, the controversial cells were thought to be the only
ones that could give rise to all tissues in the body.

"Adult" stem cells, in contrast, were presumed to resupply only the
specialized tissue -- say, blood or fat -- that harbored them.

But now scientists can genetically reprogram specialized cells to be
as versatile as embryonic ones -- albeit only in the lab, with
methods that would be unsafe in humans.

Scientific advances, media hype and public confusion have fueled stem-
cell tourism, critics say.

"There is a risk that patients who are desperate will misunderstand
the amount of progress," said Harvard University professor George
Daley, associate director of the Stem Cell Program at Children's
Hospital Boston. "It is fertile ground for exploitation."

Most stem-cell purveyors claim to use blood stem cells. These cells --
readily extracted from circulating blood, bone marrow, fetuses or
umbilical cords -- have been used since the 1960s to treat blood-
system diseases such as leukemia and lymphoma.

There is no evidence that a shot of blood stem cells can magically
fix any problem in every organ system, experts say, but that's what
stem-cell tourists are led to believe.

William Rader, a psychiatrist in Malibu, Calif., who owns the
Dominican Republic clinic where Nathan was treated, says on his Web
site that the fetal blood stem cell "searches out, detects and then
attempts to repair any damage or deficiency discovered."

Rader did not respond to requests for an interview.

Living with ambiguity Justin Lowery's case shows why mainstream
scientists want controlled studies -- and why patients won't wait.

Justin, of Carneys Point, N.J., was born blind, the result of
severely underdeveloped optic nerves.

In February, when he was 10 months old, the impact of his handicap
was obvious as physical therapist Karen Conner worked with him at
home. Justin couldn't roll onto his belly, crawl, or pull himself to
a standing position.

"What are you doing, big boy?" cooed his mother, Lora, as Conner
bounced Justin on a giant ball to strengthen his abdominal muscles.

The baby did not smile or laugh. He didn't reach for toys, even ones
with lights and sounds. He was easily startled. He recoiled at most
objects put in his hands.

Fast-forward to April, two days after Justin's first birthday --
about a month after he and his parents flew home from Beike's clinic
in Hangzhou, China.

A reporter watched as Justin's eyes followed a lighted ball that
Conner moved in front of his face. He also pulled blinking balls out
of a plastic jar, crawled to get toys, knelt, and pulled himself up
using the sofa.

He often smiled.

Jonathan Salvin, Justin's ophthalmologist at Alfred I. du Pont
Hospital for Children in Wilmington, found no change in Justin's
optic nerves but called his ability to follow objects with his
eyes "a pretty significant improvement."

Was it due to the Lowerys' $70,000 odyssey?

All Salvin could say for sure was that occasionally, vision gets
better as the brain matures early in life.

"I have seen improvement like this in kids who haven't had this
protocol," he said.

While the Lowerys can live with that ambiguity, researchers cannot.

"The unfortunate thing," said John Steeves, a spinal-cord-injury
researcher at the University of British Columbia, "is that none of us
is learning anything that advances our scientific understanding."

Immediate gains doubtful Many patients or families, including
Justin's, report neurological changes within 48 hours of receiving
stem cells.

Even stem-cell purveyors acknowledge that nerves cannot grow -- much
less regrow -- that fast.

"We believe these immediate results occur from the neural growth
factors used during the transplant process," says Beike's literature,
suggesting growth chemicals revive existing nerves.

Critics cite other factors:

Care that includes surgically opening an injured spinal cord may free
compressed nerves.

Believing is seeing, also known as the placebo effect.

No one wants to feel bilked, especially after fund-raisers and loans.

"The problem with folks who say, 'Things are a little better,' is
that they've just spent a lot of time and money," said Bruce Dobkin,
a neurologist and rehabilitation expert at the University of
California, Los Angeles. "And they think, 'Maybe I'll continue to get
better.' "

Excruciating pain Six years ago, Tim Case, a workaholic New York real
estate developer, was talked into trying an all-terrain vehicle, just
for fun, by his 11-year-old son.

Case crashed into a tree and, in a heartbeat, ended his life as an
alpha male.

Although Case, 48, is a quadriplegic, he is not as disabled as actor
Christopher Reeve, who became a friend after the accident, was before
he died. Case doesn't need a ventilator, and has limited use of his
arms and hands.

Case, however, has a problem Reeve didn't have: unrelenting,
excruciating pain.

Case believes the pain -- which was intermittent and tolerable after
the accident -- was exacerbated by the cell transplant he received in
2003 from neurosurgeon Huang Hongyun in Beijing.

"I think it's just as important to report the negative as the
positive," Case said last month from a wheelchair in his Long Island
home.

Doctors used to dismiss such pain as imaginary. After all, how can a
limb that can't feel a pinprick feel pain? It is now clear that
broken nerves can send dysfunctional signals to the brain.

As Case can attest, these signals can defy pain drugs, including
opiates.

On CareCure, an online patient-support forum run by Rutgers' Young,
Case begged for advice.

"By 4:30 a.m., I am awake, screaming in pain, stiffness, burning,
very high spasm," he wrote in 2006. "Pain is killing, just
overwhelming."

Early last year, he wrote: "There has to be an efficient way to end
my life. Some way to end the pain."

Has it lessened since then?

"As I tell my wife," he said with a sad smile, "the only thing that
seems to change is my ability to tolerate more pain."

Still, he insisted the treatment had been worth the risk. He would
try a newer version if he thought it would help.

"We're desperate," he said. "There's nothing else."

Operations in China That, Huang and other purveyors say, is why cells
should be used even though it is not clear how they work.

"It is more reasonable and respectful to the patients," Huang e-
mailed last month. "Any standard should consider patients as the key
factor."

Huang worked at Rutgers for three years under Young's tutelage,
surgically implanting specialized cells into rats with spinal
injuries. While these cells are not stem cells, they are believed to
be key to the olfactory (smell) system's ability to replenish nerves -
- something no other part of the nervous system can do.

In 2002, Huang returned to Beijing and began offering the rat
operation to humans. He said that on the standard neurological-
impairment scale, patients had gained at least one grade of motor
function -- such as extending a formerly paralyzed wrist. Soon he
expanded the treatment to other problems, such as stroke and
amyotrophic lateral sclerosis. He also traveled widely, talking up
his methods to Western scientists.

Young, who was born in Hong Kong, has urged his former protege to
conduct controlled studies, called clinical trials -- as Young plans
to do late this year with doctors he has trained in China.

Huang "is delivering a treatment that he believes is effective,"
Young said. "But I have strongly discouraged him. The Chinese
government dislikes it."

Huang insisted that officials did not object to his procedure, which
he called safe.

Of 1,255 patients treated through last year, 76 had
complications, "including temporary headache, temporary modest fever,
incision infection, cerebrospinal fluid leakage, etc."

For another view, UCLA's Dobkin and two colleagues found seven
patients who planned to get Huang's cell transplants for spinal-cord
injuries.

The Western doctors examined the patients before, after, and up to a
year later.

Their tiny study, published in 2006 in Neurorehabilitation and Neural
Repair, found that five of the seven patients had serious side
effects, including pneumonia, bleeding and meningitis.

None had significant improvements.

Going back for more And what of Marcela DeVivo, who hoped fetal stem
cells would work miracles for her then-18-month-old son?

Her blog has photos of that February trip to the Dominican Republic:
Here is Nathan, with his megawatt smile, gazing at Rader, the Malibu
psychiatrist.

Other photos show Nathan laughing as his mom dips him in the surf, or
being held by his father, Owen Andrew.

But there were no miracles.

DeVivo said the treatment still had been worth it. "I see little
changes, which in a child like Nathan are important," she wrote. "His
head and trunk are stronger. He is more alert. His tongue is moving
better."

Back home, DeVivo again threw herself into obtaining anything that
might help Nathan, from physical and speech therapy to "transcranial
manipulation."

By May, "tired and overwhelmed," she had an epiphany: "I can't fix
Nathan."

"Most importantly, Nathan doesn't need fixing. . . . Maybe he is here
to fix me."

Still, she said recently, she can never stop seeking therapies to
help keep him healthy by preventing related problems, such as hip
dislocation and spinal curvature.

And those therapies include stem cells.

"We're going back in August for more stem cells," she said. "Going
back, it's less expensive -- $12,000."

Contact staff writer Marie McCullough at 215-854-2720 or
mmccullough@phillynews.com.

-----

To see more of The Philadelphia Inquirer, or to subscribe to the
newspaper, go to http://www.philly.com.

Copyright (c) 2008, The Philadelphia Inquirer

Distributed by McClatchy-Tribune Information Services.

For reprints, email tmsreprints@permissionsgroup.com, call 800-374-
7985 or 847-635-6550, send a fax to 847-635-6968, or write to The
Permissions Group Inc., 1247 Milwaukee Ave., Suite 303, Glenview, IL
60025, USA.

Source: The Philadelphia Inquirer
http://www.redorbit.com/news/health/1475332/stemcell_tourism_troubles_
experts/

__._,_.___
____________________________________________
«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»«¤»¥«¤»§«¤»¥«¤»§«¤»¥«
¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
StemCells subscribers may also be interested in these sites:

Children's Neurobiological Solutions
http://www.CNSfoundation.org/

Cord Blood Registry
http://www.CordBlood.com/at.cgi?a=150123

The CNS Healing Group
http://groups.yahoo.com/group/CNS_Healing
____________________________________________
«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»«¤»¥«¤»§«¤»¥«¤»§«¤»¥«
¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
MARKETPLACE

Special offer for Yahoo! Groups from Blockbuster! Get a free 1-month trial with no late fees or due dates.
Recent Activity
Visit Your Group
Yahoo! News

Get it all here

Breaking news to

entertainment news

Yahoo! Finance

It's Now Personal

Guides, news,

advice & more.

Y! Groups blog

the best source

for the latest

scoop on Groups.

.

__,_._,___

1 comment:

Julie said...

It looks like tourism of cells had become a common thing. I am a doctor and I ususally have to travel to different countries taking chemicals from laboratories to other ones for examination. Last year I a dto go to Argentina. The good thing about my job is that you get good things as an apartment rental in Buenos Aires and some days off for the professional to meet the country. It is great, isn´t it?
I highly recommend BA, is one of the most developed cities in Latin America!
Julie



about stem cell research
adult stem cell
adult stem cell research
adult stem cells
against stem cell
against stem cell research
anti stem cell
anti stem cell research
autologous stem cell
autologous stem cell transplant
benefits of stem cell research
blood stem cells
bone marrow stem cells
bush stem cell
california stem cell
cancer stem cell
cancer stem cells
cell stem cell
cons of stem cell research
cord blood stem cell
cord blood stem cells
cord stem cells
diabetes stem cell
embryonic stem cell
embryonic stem cell research
embryonic stem cells
for stem cell research
funding for stem cell research
harvard stem cell
harvard stem cell institute
hematopoietic stem cell
hematopoietic stem cells
history of stem cell research
human embryonic stem cell
human embryonic stem cell research
human embryonic stem cells
international stem cell
mesenchymal stem cell
mesenchymal stem cells
neural stem cell
neural stem cells
nih stem cell
pluripotent stem cells
pro stem cell
pro stem cell research
pros and cons of stem cell
pros and cons of stem cell research
stem cell
stem cell bank
stem cell bill
stem cell biology
stem cell companies
stem cell conference
stem cell controversy
stem cell cures
stem cell debate
stem cell differentiation
stem cell ethics
stem cell funding
stem cell heart
stem cell information
stem cell institute
stem cell line
stem cell lines
stem cell news
stem cell policy
stem cell reasearch
stem cell reaserch
stem cell reseach
stem cell research
stem cell research articles
stem cell research bill
stem cell research controversy
stem cell research debate
stem cell research enhancement act
stem cell research ethics
stem cell research facts
stem cell research funding
stem cell research pros
stem cell research pros and cons
stem cell reserach
stem cell reserch
stem cell technologies
stem cell technology
stem cell therapy
stem cell transplant
stem cell transplantation
stem cell transplants
stem cell treatment
stem cell treatments
stem cell veto
stem cells
stem cells research
support stem cell research
types of stem cells
umbilical cord stem cells
what are stem cells
what is a stem cell
what is stem cell
what is stem cell research